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EPI Update for Friday, February 10, 2006  
Center for Acute Disease Epidemiology 
Iowa Department of Public Health (IDPH) 
 
 
Items for this week’s EPI Update include: 
• Imported Vaccine-Associated Paralytic Poliomyelitis  
• Influenza Update 
• FDA Approves New Laboratory Test To Detect Human Infections With 
Avian Influenza A/H5 Viruses 
• Mumps Testing Update 
• EPI Update Survey (Below) Please complete and reply 
 
Imported Vaccine-Associated Paralytic Poliomyelitis 
 
The Feb 3, 2006 issue of the CDC’s MMWR contains a report on vaccine-related polio 
virus infecting a 22-year-old female U.S. citizen while visiting Central and South 
America on a study-abroad program. The patient became ill with fever, malaise, neck and 
back pain, and ultimately respiratory failure and paralysis. Stool cultures identified 
Sabin-strain poliovirus types 2 & 3, found in oral polio vaccine (OPV) preparations. She 
subsequently recovered respiratory function but still had residual weakness in both legs 
two months later. 
 
The patient had never been vaccinated with either OPV (oral polio vaccine) or injected 
polio vaccine (IPV) because of a religious exemption. The patient was likely exposed to 
live Polio-vaccine virus, OPV when she stayed with a host family whose 2 month old 
infant had been immunized with live oral Polio vaccine just 4 days prior to the patient’s 
arrival.  
 
This case highlights the need for people who travel out of the U.S. to be well protected 
from vaccine preventable diseases. Adults who are unvaccinated, incompletely 
vaccinated, or whose vaccination status is unknown should receive IPV before traveling 
to areas where polio is epidemic or endemic. The risk for a traveler for contracting 
paralytic disease much greater in a polio-endemic country or outbreak country (e.g., 
Nigeria) than in an OPV-using country that is free from wild poliovirus.  This case, 
however, shows that there is also some risk for unvaccinated people who visit countries 
where live polio vaccine is still used.  More information on specific vaccination 
recommendations can be found in the Epi Manual at 
http://www.idph.state.ia.us/adper/surveillance_manual.asp 
 
Influenza Update 
 
Seasonal Influenza: Iowa and the United States  
Iowa continues at regional activity.  Influenza-like illness is increasing slowly in all 
reporting populations.  Schools in Polk and Sioux Counties reported overall student 
absenteeism greater than >10% on several days last week.  For more information on the 
Iowa Influenza Surveillance Network or to view our activity map, visit our Web site 
at http://www.idph.state.ia.us/adper/iisn.asp. 
 
Avian Influenza 
Confirmation of H5N1 in one large commercial poultry farm in Nigeria marks further 
geographical spread of the virus.  Experience in several other countries has shown how 
quickly the H5N1 virus can spread and become firmly established in poultry.  In Nigeria, 
as in other parts of Africa, most village households maintain free-ranging flocks of 
poultry as a source of income and food. Close human contact with poultry is extensive, 
though the virus still does not spread easily from bird to human. Only in one case has it 
spread from human to human.   
 
The World Health Organization (WHO) has confirmed several more cases in Turkey that 
were previously reported by Turkish health authorities.  As of Feb. 9th, 166 cases have 
been confirmed including 88 deaths.  The single case reported in Iraq was also a fatality.  
The only country with sustained, consistent case reports of human illness is China. 
   
Pandemic Influenza Planning Efforts  
More than 400 people attended the Pandemic Influenza Summit held in Des Moines on 
Feb. 3. Video footage of the summit is available on the IDPH Web site at 
www.idph.state.ia.us/pandemic. A variety of fact sheets on influenza are also available at 
this site.  
 
FDA Approves New Laboratory Test To Detect Human Infections With Avian 
Influenza A/H5 Viruses 
  
On Feb. 3, the U.S. Department of Health and Human Services (HHS) announced that the 
Food and Drug Administration (FDA) has approved a new rapid test to diagnose 
infection with H5 strains of influenza (i.e. Bird Flu). The test is called, the Influenza 
A/H5 (Asian lineage) Virus Real-time RT-PCR Primer and Probe Set.  It will be 
distributed to Laboratory Response Network (LRN)-designated laboratories to enhance 
early detection and surveillance activities.  The University Hygienic Laboratory (UHL) is 
the LRN laboratory for the state of Iowa.  UHL participated in the validation studies 
conducted by the CDC on this test and will use it to replace the older version of the A/H5 
RT-PCR test. 
  
Mumps Testing Update 
 
There have been a number of reports of patients with mumps-like symptoms as well as 
several laboratory confirmed cases of mumps this year in Iowa.  An updated mumps 
chapter for the IDPH Epi Manual and a case follow-up form were discussed in last 
week’s EPIUpdate and can be found at 
http://www.idph.state.ia.us/adper/surveillance_manual.asp.  
 
It is difficult to clinically differentiate mumps from other conditions causing parotid 
swelling.  Parotitis can be caused by adenovirus, Epstein-Barr virus, parainfluenza virus 
types 1 and 3, influenza A virus, Coxsackie A virus, echovirus, lymphocytic 
choriomeningitis virus, HHV-6, and human immunodeficiency virus.  Parotitis can also 
occur due to non-infectious causes.   Lab tests are needed for diagnosis and subsequent 
treatment.   
 
Laboratory tests should be collected on individual cases and on 2 or 3 individuals out of a 
cluster who have acute illness and symptoms most consistent with disease.  Blood should 
be tested for IgM antibodies during the acute phase of illness, optimally 4 to 5 days after 
onset of symptoms.  Paired acute and convalescent serum specimens are recommended 
for IgG testing because false positive IgM results can occur.  Additionally, collecting a 
throat swab after the parotid glands have been massaged and collecting urine for mumps 
virus isolation is recommended.  The specimens submitted for viral culture should be 
collected as soon as possible after onset of symptoms and within the first 5 days of 
parotitis.   
 
Collect 
• Serum for IgM and  IgG antibody detection. 
• Throat swab for viral culture in M4 transport media tube (pink fluid), 
massaging the parotid and salivary glands prior to swabbing the throat at the 
stensen’s duct orifice (level with upper 2nd molar).  Laboratories have M4 
transport tubes available in the Biodefense Kits (blue box) or viral collection 
kits.  If M4 transport media is needed, contact UHL. 
• Urine - clean catch - for mumps virus isolation 
Clinical specimens should be delivered to UHL as soon as possible and no later than 4 
days after collection.  Specimens should be kept cold during transport, but not frozen. 
 
A person with acute illness should stay home.  The appropriate treatment is supportive 
care.  The case should be isolated during the infectious period (for nine days after onset 
of parotid swelling).  There are no effective post-exposure recommendations to prevent 
secondary cases in contacts, but susceptibles should be vaccinated to prevent tertiary 
cases.  Birth before 1957 does not guarantee mumps immunity.  In outbreak settings 
vaccination with mumps containing vaccine, preferably MMR, should be considered for 
anyone who has not received 2 doses of vaccine. 
 
EPI Update Survey 
 
“Epi Update” Survey      From: Patricia Quinlisk, MD, MPH  2-
10-06 
 
The Iowa Department of Public Health is conducting this brief survey to assess the 
impact that this newsletter has on YOU. Your feedback is critical for us to improve upon 
the content and ensure that the newsletter meets your needs. The survey results will be 
available in March ’06. Your email address and any identifying responses will be kept 
confidential. 
 
This should take only 2-3 minutes. THANK YOU! 
 
1) Click on reply so you can enter your answers. 
2) Type an X to the left of the best fitting answers .   
3) Click send to email your answers back to us.  
 
1. Which ONE of the following categories best describes you:  
______A) Healthcare professional (physician, nurse, veterinarian, public health worker, 
etc.) 
______B) Healthcare student (medicine, veterinary, nursing, public health, etc.) 
______C) Teacher (grade school, high school, university, vocational, etc.)  
______D) Government worker (public official, lobbyist, secretary, etc.) 
______E) Journalist (any media representative) 
______F) Other type of professional: __________________________________ 
______G) General Public 
 
2. Select your primary location:  
______A) County in Iowa, specify: ____________________________________ 
______B) State surrounding Iowa:  
____Minnesota 
____Wisconsin 
____Illinois 
____Missouri 
____South Dakota 
____Nebraska 
____Kansas  
______D) Other states in the USA –specify state: __________________________ 
______E) Other country: _____________________________________________ 
 
3. How has reading the EPI Update impacted you? (Select ALL THAT APPLY.)  
EPI Update: 
______A) has never changed any part of my professional or personal activities 
______B) has given me something interesting to read each Friday 
______C) has changed personal activities (cooking, hand washing, swimming, etc.)  
  Give examples:_________________________________________ 
______D) is a valuable tool in professional activities (giving vaccinations, finding  
information, helping make recommendations, etc.) 
  Give examples:__________________________________________ 
______E) Other – please explain________________________________________ 
______________________________________________________ 
 
4. In the EPI update, you need information on:  (Select ALL THAT APPLY.)  
______A) Specific agents causing Infectious Diseases (ID) (Influenza, rabies, hepatitis, 
etc.)  
______B) Vaccinations 
______C) Rare diseases (Human Botfly, Mad Cow Disease, etc.) 
______D) Local or state ID issues (outbreaks, diseases happening in Iowa, etc.) 
______E) Bordering states ID issues 
______F) International or national ID issues 
______G) Pharmaceuticals (antibiotics, anti-virals, immunoglobulin, etc.) 
______H) Iowa legislation on ID issues 
______I) Behavioral issues that relate to ID (smoking, food, stress, cancer, obesity, etc.) 
______J) Upcoming events, conferences or training on ID and public health 
______K) Health Alerts from the CDC (no longer recommending some anti-virals for the flu) 
______L) Other –please specify: ________________________________________ 
COMMENTS:____________________________________________________ 
 
5. You are currently satisfied with the information on: (Select ALL THAT 
APPLY.)  
______A) Specific agents causing Infectious Diseases (ID) (Influenza, rabies, hepatitis, 
etc.) 
______B) Vaccinations 
______C) Rare diseases (Human Botfly, Mad Cow Disease, etc.) 
______D) Local or state ID issues (outbreaks, diseases happening in Iowa, etc.) 
______E) Bordering states ID issues 
______F) International or national ID issues 
______G) Pharmaceuticals (antibiotics, anti-virals, immunoglobulin, etc.) 
______H) Iowa legislation on ID issues 
______I) Behavioral issues that relate to ID (smoking, food, stress, cancer, obesity, etc.) 
______J) Upcoming events, conferences or training on ID and public health 
______K) Health Alerts from the CDC (no longer recommending some anti-virals for the flu) 
______L) Other –please specify: ________________________________________ 
COMMENTS:____________________________________________________ 
 
6. Information in following areas should be improved upon: (Select ALL THAT 
APPLY.)  
______A) Specific agents causing Infectious Diseases (ID) (Influenza, rabies, hepatitis, 
etc.) 
______B) Vaccinations 
______C) Rare diseases (Human Botfly, Mad Cow Disease, etc.) 
______D) Local or state ID issues (outbreaks, diseases happening in Iowa, etc.) 
______E) Bordering states ID issues 
______F) International or national ID issues 
______G) Pharmaceuticals (antibiotics, anti-virals, immunoglobulin, etc.) 
______H) Iowa legislation on ID issues 
______I) Behavioral issues that relate to ID (smoking, food, stress, cancer, obesity, etc.) 
______J) Upcoming events, conferences or training on ID and public health 
______K) Health Alerts from the CDC (no longer recommending some anti-virals for the flu) 
______L) Other –please specify: ________________________________________ 
COMMENTS:____________________________________________________ 
 
7. The EPI Update should contain MORE information on which diseases:  
(Select ALL THAT APPLY.) 
______A) Influenza (human, avian, swine, etc.) 
______B) Rabies 
______C) Hepatitis (type A, B, C) 
______D) Food-borne illnesses (Salmonella, E. coli, Giardia, etc.) 
______E) West Nile virus 
______F) Pertussis (whooping cough) 
______G) Meningitis 
______H) Rare diseases (Human Botfly, leprosy, histoplasmosis, tuberculosis, etc.) 
______I) Other disease(s) ______________________________________________ 
 
8. The EPI Update should contain LESS information on which diseases:  
(Select ALL THAT APPLY.) 
______A) Influenza (human, avian, swine, etc.) 
______B) Rabies 
______C) Hepatitis (type A, B, C) 
______D) Food-borne illnesses (Salmonella, E. coli, Giardia, etc.) 
______E) West Nile virus 
______F) Pertussis (whooping cough) 
______G) Meningitis 
______H) Rare diseases (Human Botfly, leprosy, histoplasmosis, tuberculosis, etc.) 
______I) Other disease(s) _____________________________________________ 
 
9. Select what best describes the technical reading level in the EPI Update:  
______A) Overly technical 
______B) Appropriately technical  
______C) Not technical enough 
COMMENTS:____________________________________________________ 
 
10. Select what best describes the overall amount of information in the EPI Update:  
______A) too much information –needs to be more concise  
______B) an appropriate amount of information 
______C) too little relevant information –needs more depth  
COMMENTS:____________________________________________________ 
 
11. Select from where you receive the EPI Update:  
______A) directly from the Iowa Department of Public Health 
______B) through a professional organization/society list server 
______C) from a list server or forwarding through my work place 
______D) from another individual forwarding it (family, friend, etc.) 
______E) Other: _____________________________________________________ 
 
12. On what weekday is it most useful to receive the EPI Update?  
______A) Monday 
______B) Tuesday 
______C) Wednesday 
______D) Thursday 
______E) Friday 
 
13. The epidemiology learning item with 5 questions in a newsletter and the answers 
in the next newsletter (“EPI 5”) is:  
______A) a great learning tool and I wish such questions were in every update 
______B) a nice refresher and I wish such questions were included about once per month 
______C) nice to have about once per year 
______D) not helpful and should not be included 
COMMENTS:____________________________________________________ 
 
14. Regarding humorous and/or epidemiologically interesting stories (e.g. 
Epidemiology of Christmas Fever, or story about a live raccoon in back of a 
someone’s car), such stories:  
______A) should be included MORE 
______B) are included enough  
______C) should NOT be included 
COMMENTS:____________________________________________________ 
 
15. The historical perspective articles (e.g. the Avian Flu epidemic at Grinnell 
College in Iowa during the 1950s):  
______A) are very important and should be included regularly 
______B) are somewhat important, and should be included only when relevant to current 
events 
______C) should not be included 
COMMENTS:____________________________________________________ 
 
16. The announcements, conferences and training events are:  
______A) important because I attended events found within or often used the information 
______B) interesting to read about, but I have seldom used the information 
______C) not to be included 
COMMENTS:____________________________________________________ 
 
17. The Internet links included for further information are:  
______A) very useful –I clicked on some each week and was satisfied 
______B) somewhat useful –I clicked on several of them and was satisfied 
______C) not useful –I clicked on several of them and was NOT satisfied 
______D) I have never used any of the reference links 
______E) Other: _____________________________________________________ 
COMMENTS:____________________________________________________ 
 
18. In this section, please provide any additional suggestions or comments to help us 
make the EPI Update as helpful as 
possible.______________________________________________________  
_____________________________________________________________ 
 
THANK YOU! for your participation in this questionnaire. If you have questions, 
comments or would like to see the results of this survey, please contact our MPH intern 
Philip Bovet at: PBovet@idph.state.ia.us, IDPH phone number: 1-800-362-2736 or 515-
242-5935. If you would like to visit our EPI Update archive page, then click on the 
following link: http://www.idph.state.ia.us/adper/epi_update.asp.  
 
 
Have a healthy and happy week! 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health 
800-362-2736 
 
 
